BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshizumi T, Taketomi A, Soejima Y, Ikegami T, Uchiyama H, Kayashima H, Harada N, Yamashita Y, Kawanaka H, Nishizak T. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int. 2008;21:833-842. [PMID: 18482177 DOI: 10.1111/j.1432-2277.2008.00678.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 87] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Yoshizumi T, Shirabe K, Taketomi A, Uchiyama H, Harada N, Ijichi H, Yoshimatsu M, Ikegami T, Soejima Y, Maehara Y. Risk factors that increase mortality after living donor liver transplantation. Transplantation. 2012;93:93-98. [PMID: 22203391 DOI: 10.1097/tp.0b013e318238dacd] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
2 Akamatsu N, Sugawara Y. Living-donor liver transplantation and hepatitis C. HPB Surg 2013;2013:985972. [PMID: 23401640 DOI: 10.1155/2013/985972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Senzolo M, Rodriguez K, Nadal E, Burra P. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916). Br J Surg. 2010;97:1452; author reply 1452-1453. [PMID: 20683871 DOI: 10.1002/bjs.7002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
4 Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S. Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Am J Transplant 2019;19:2783-94. [PMID: 30830721 DOI: 10.1111/ajt.15337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
5 Yoshizumi T, Mori M. Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today 2020;50:21-9. [PMID: 31555908 DOI: 10.1007/s00595-019-01881-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Yoichi T, Takayashiki T, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Kuboki S, Okamura D, Suzuki D, Nakajima M, Miyazaki M. Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation. Transpl Int 2014;27:106-13. [DOI: 10.1111/tri.12223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Imai D, Ikegami T, Toshima T, Yoshizumi T, Yamashita Y, Ninomiya M, Harimoto N, Itoh S, Uchiyama H, Shirabe K, Maehara Y. Preemptive Thoracic Drainage to Eradicate Postoperative Pulmonary Complications after Living Donor Liver Transplantation. Journal of the American College of Surgeons 2014;219:1134-1142.e2. [DOI: 10.1016/j.jamcollsurg.2014.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Koh TS, Thng CH, Hartono S, Choo SP, Ng QS, Khoo JB, Bisdas S, Koh DM. Deconvolution assessment of splenic and splanchnic contributions to portal venous blood flow in liver cirrhosis. Med Phys 2011;38:2768-82. [PMID: 21776814 DOI: 10.1118/1.3582691] [Reference Citation Analysis]
9 Choi WK, Kim J, Choi HJ, Hong SH, Chae MS. Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis: A case report. Medicine (Baltimore) 2021;100:e24298. [PMID: 33466218 DOI: 10.1097/MD.0000000000024298] [Reference Citation Analysis]
10 Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Yamashita Y, Harimoto N, Toshima T, Uchiyama H, Soejima Y, Maehara Y. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Surg Today 2014;44:233-40. [DOI: 10.1007/s00595-013-0523-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
11 Kawanaka H, Akahoshi T, Itoh S, Iguchi T, Harimoto N, Uchiyama H, Yoshizumi T, Shirabe K, Takenaka K, Maehara Y. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension. J Am Coll Surg. 2014;219:865-874. [PMID: 25256370 DOI: 10.1016/j.jamcollsurg.2014.07.939] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
12 Uchiyama H, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Harimoto N, Maehara Y. Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl. 2016;22:305-315. [PMID: 26610068 DOI: 10.1002/lt.24378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
13 Takahashi Y, Matsuura T, Yoshimaru K, Yanagi Y, Hayashida M, Taguchi T. Liver graft-to-spleen volume ratio as a useful predictive factor of the early graft function in children and young adults transplanted for biliary atresia: a retrospective study. Transpl Int. 2018;31:620-628. [PMID: 29424478 DOI: 10.1111/tri.13131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yoshizumi T, Shirabe K, Soejima Y, Taketomi A, Yamashita N, Ikegami T, Uchiyama H, Kayashima H, Ninomiya M, Maehara Y. Living Donor Liver Transplantation in Patients Older Than 60 Years. Transplantation 2010;90:433-7. [DOI: 10.1097/tp.0b013e3181e81b2d] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
15 Badawy A, Hamaguchi Y, Satoru S, Kaido T, Okajima H, Uemoto S. Evaluation of safety of concomitant splenectomy in living donor liver transplantation: a retrospective study. Transpl Int. 2017;30:914-923. [PMID: 28512755 DOI: 10.1111/tri.12985] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
16 Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y. Left lobe living donor liver transplantation in adults: What is the safety limit? Liver Transpl. 2016;22:1666-1675. [PMID: 27540888 DOI: 10.1002/lt.24611] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
17 Ikegami T, Onda S, Furukawa K, Haruki K, Shirai Y, Gocho T. Small-for-size graft, small-for-size syndrome and inflow modulation in living donor liver transplantation. J Hepatobiliary Pancreat Sci 2020;27:799-809. [PMID: 32897590 DOI: 10.1002/jhbp.822] [Reference Citation Analysis]
18 Moon DB, Lee SG, Hwang S, Ahn CS, Kim KH, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Cho HD, Kwon JH, Jung YK, Ha SM. Splenic devascularization can replace splenectomy during adult living donor liver transplantation - a historical cohort study. Transpl Int 2019;32:535-45. [PMID: 30714245 DOI: 10.1111/tri.13405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
19 Imai D, Yoshizumi T, Sakata K, Ikegami T, Itoh S, Harada N, Motomura T, Toshima T, Mano Y, Soejima Y, Maehara Y. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation. Transplantation 2018;102:e382-91. [PMID: 29912047 DOI: 10.1097/TP.0000000000002324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
20 Fu Y, Zhang H, Yang N, Zhu N, Si-ma H, Chen W, Zhao W, Yang G. Porcine Partial Liver Transplantation Without Veno-venous Bypass: An Effective Model for Small-for-Size Liver Graft Injury. Transplantation Proceedings 2011;43:1953-61. [DOI: 10.1016/j.transproceed.2011.01.173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Serenari M, Cescon M, Cucchetti A, Pinna AD. Liver function impairment in liver transplantation and after extended hepatectomy. World J Gastroenterol 2013; 19(44): 7922-7929 [PMID: 24307786 DOI: 10.3748/wjg.v19.i44.7922] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
22 Riddiough GE, Christophi C, Jones RM, Muralidharan V, Perini MV. A systematic review of small for size syndrome after major hepatectomy and liver transplantation. HPB (Oxford) 2020;22:487-96. [PMID: 31786053 DOI: 10.1016/j.hpb.2019.10.2445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
23 Abshagen K, Eipel C, Vollmar B. A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg. 2012;397:579-590. [PMID: 22311102 DOI: 10.1007/s00423-012-0913-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
24 Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010;251:76-83. [PMID: 19864937 DOI: 10.1097/sla.0b013e3181bdf8ad] [Cited by in Crossref: 79] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
25 Miyagi Y, Kinjo T, Yoshizumi T, Harada N, Arakaki S, Kinjo T, Hokama A, Takatsuki M. Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report. Surg Case Rep 2020;6:278. [PMID: 33130979 DOI: 10.1186/s40792-020-01059-6] [Reference Citation Analysis]
26 Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg. 2009;16:749-757. [PMID: 19629372 DOI: 10.1007/s00534-009-0149-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
27 Salimi S, Pandya K, Sastry V, West C, Virtue S, Wells M, Crawford M, Pulitano C, McCaughan GW, Majumdar A, Strasser SI, Liu K. Impact of Having a Planned Additional Operation at Time of Liver Transplant on Graft and Patient Outcomes. J Clin Med 2020;9:E608. [PMID: 32102393 DOI: 10.3390/jcm9020608] [Reference Citation Analysis]
28 Li C, Wen TF, Yan LN. Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation 2014;97:e33. [PMID: 24637870 DOI: 10.1097/TP.0000000000000036] [Reference Citation Analysis]
29 Zhang Y, Yan L, Wen T, Li B, Zhao J, Chen Z, Wang W, Xu M, Yang J, Wei Y, Ma Y, Jiang L. Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy. Journal of Surgical Research 2012;178:478-86. [DOI: 10.1016/j.jss.2012.02.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Golriz M, Majlesara A, Khajeh E, Rezaei N, Saffari A, Arwin J, Hafezi M, El Sakka S, Abbasi S, Emami G, Ramouz A, Mehrabi A. Portocaval shunt can optimize transhepatic flow following extended hepatectomy: a short-term study in a porcine model. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05327-3] [Reference Citation Analysis]
31 Li D, Du C, Fan B, Huang P, Luo S, He Q. Impact of simultaneous splenectomy and orthotopic liver transplantation in patients with end-stage liver diseases and splenic hyperfunction. Hepatobiliary & Pancreatic Diseases International 2012;11:489-93. [DOI: 10.1016/s1499-3872(12)60212-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Yoshizumi T, Ikegami T, Toshima T, Harimoto N, Uchiyama H, Soejima Y, Yamashita Y, Shirabe K, Maehara Y. Two-step Selection Criteria for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2013;45:3310-3. [DOI: 10.1016/j.transproceed.2013.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
33 Mori S, Park MS, Kim H, Choi Y, Hong G, Yi NJ, Lee KW, Suh KS. Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. Int Surg. 2015;100:524-530. [PMID: 25785339 DOI: 10.9738/intsurg-d-14-00016.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Yoshizumi T, Ikegami T, Yoshiya S, Motomura T, Mano Y, Muto J, Ikeda T, Soejima Y, Shirabe K, Maehara Y. Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res 2013;43:709-16. [PMID: 23190306 DOI: 10.1111/hepr.12016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
35 Reyal J, Uemoto S. Percutaneously adjustable portal vein banding device could prevent post-operative liver failure – Artificial control of portal venous flow is the key to a new therapeutic world. Medical Hypotheses 2009;73:640-50. [DOI: 10.1016/j.mehy.2009.08.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
36 Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, Iguchi T, Hashimoto N, Maehara Y. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation. 2009;88:303-307. [PMID: 19667930 DOI: 10.1097/tp.0b013e3181adcae6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
37 Sanefuji K, Iguchi T, Ueda S, Nagata S, Sugimachi K, Ikegami T, Gion T, Soejima Y, Taketomi A, Maehara Y. New prediction factors of small-for-size syndrome in living donor adult liver transplantation for chronic liver disease. Transpl Int. 2010;23:350-357. [PMID: 19843295 DOI: 10.1111/j.1432-2277.2009.00985.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
38 Ijichi H, Shirabe K, Matsumoto Y, Yoshizumi T, Ikegami T, Kayashima H, Morita K, Toshima T, Mano Y, Maehara Y. Evaluation of graft stiffness using acoustic radiation force impulse imaging after living donor liver transplantation. Clin Transplant 2014;28:1256-62. [DOI: 10.1111/ctr.12457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Jin S, Dai CL. Splenectomy in patients with liver cirrhosis and portal hypertension. Shijie Huaren Xiaohua Zazhi 2010; 18(33): 3533-3538 [DOI: 10.11569/wcjd.v18.i33.3533] [Reference Citation Analysis]
40 Fukuhara T, Morita K, Takeishi K, Toshima T, Umeda K, Nagata S, Sugimachi K, Ikegami T, Gion T, Soejima Y, Taketomi A, Maehara Y. Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: Report of a case. Surg Today 2010;40:982-5. [DOI: 10.1007/s00595-009-4168-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
41 Yoshizumi T, Itoh S, Shimokawa M, Inokuchi S, Harada N, Takeishi K, Mano Y, Yoshiya S, Kurihara T, Nagao Y, Ikegami T, Soejima Y, Mori M. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. Journal of Hepatology 2021;74:372-9. [DOI: 10.1016/j.jhep.2020.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Taniguchi M, Shimamura T, Todo S, Furukawa H. Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today. 2015;45:663-671. [PMID: 24894564 DOI: 10.1007/s00595-014-0945-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
43 Ikegami T, Balci D, Jung DH, Kim JM, Quintini C. Living donor liver transplantation in small-for-size setting. Int J Surg 2020;82S:134-7. [PMID: 32738547 DOI: 10.1016/j.ijsu.2020.07.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J, Matono R, Taketomi A, Uchiyama H, Maehara Y. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl. 2011;17:1073-1080. [PMID: 21542128 DOI: 10.1002/lt.22324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
45 Yoshizumi T, Ikegami T, Bekki Y, Ninomiya M, Uchiyama H, Iguchi T, Yamashita Y, Kawanaka H, Shirabe K, Maehara Y. Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern era: Prediction of Graft Survival. Liver Transpl 2014;20:323-32. [DOI: 10.1002/lt.23804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
46 Golriz M, Majlesara A, Khajeh E, Mehrabi A. Reply: Hepatic Hemodynamic Changes Following Stepwise Liver Resection (Golriz et al. J Gastrointest Surg (2016) 20:587-594). J Gastrointest Surg 2016;20:2109-10. [PMID: 27604887 DOI: 10.1007/s11605-016-3261-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Toshima T, Yoshizumi T, Inokuchi S, Kosai-fujimoto Y, Kurihara T, Yoshiya S, Mano Y, Takeishi K, Itoh S, Harada N, Ikegami T, Soejima Y, Shimokawa M, Maehara Y, Mori M. Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation. HPB 2020;22:511-20. [DOI: 10.1016/j.hpb.2019.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
48 Quintini C, Miller CM. Pushing the envelope and making every organ count: Small pediatric grafts for adult recipients. Pediatr Transplant 2015;19:813-4. [PMID: 26767487 DOI: 10.1111/petr.12631] [Reference Citation Analysis]
49 Perera MT, Mirza DF, Elias E. Liver transplantation: Issues for the next 20 years. J Gastroenterol Hepatol. 2009;24 Suppl 3:S124-S131. [PMID: 19799690 DOI: 10.1111/j.1440-1746.2009.06081.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
50 Masuda Y, Yoshizawa K, Ohno Y, Mita A, Shimizu A, Soejima Y. Small-for-size syndrome in liver transplantation: Definition, pathophysiology and management. Hepatobiliary Pancreat Dis Int 2020;19:334-41. [PMID: 32646775 DOI: 10.1016/j.hbpd.2020.06.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Kwon SW, Ko GY, Kim KW. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier. Liver Transpl 2010;16:491-8. [PMID: 20222051 DOI: 10.1002/lt.22016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
52 Nobuoka Y, Wada H, Mizuno S, Kishiwada M, Usui M, Sakurai H, Tabata M, Kobayashi T, Nobori T, Uemoto S, Isaji S. Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol 2014;99:418-28. [PMID: 24595551 DOI: 10.1007/s12185-014-1543-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
53 Yoshizumi T, Shirabe K, Ikegami T, Kayashima H, Yamashita N, Morita K, Masuda T, Hashimoto N, Taketomi A, Soejima Y, Maehara Y. Impact of Human T Cell Leukemia Virus Type 1 in Living Donor Liver Transplantation: Impact of HTLV-1 Following LDLT. American Journal of Transplantation 2012;12:1479-85. [DOI: 10.1111/j.1600-6143.2012.04037.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
54 Morita K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ikegami T, Yoshizumi T, Ishigami K. Congestion Area of the Right Lobe Graft in Living Donor Liver Transplantation: Quantitative Evaluation of Hemodynamics Using Computed Tomography Perfusion. Transplant Proc 2021;53:1653-8. [PMID: 33962770 DOI: 10.1016/j.transproceed.2021.02.024] [Reference Citation Analysis]
55 Cheng Z, Yu F, Tian J, Guo P, Li J, Chen J, Fan Y, Zheng S. A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization. J Thromb Thrombolysis. 2015;40:294-301. [PMID: 25698403 DOI: 10.1007/s11239-015-1190-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
56 Chen PX, Yan LN, Wang WT. Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts. World J Gastroenterol 2014; 20(1): 282-289 [PMID: 24415883 DOI: 10.3748/wjg.v20.i1.282] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
57 Kuriyama N, Isaji S, Kishiwada M, Ohsawa I, Hamada T, Mizuno S, Usui M, Sakurai H, Tabata M, Yamada T. Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats: Dual Cytoprotective Effects of Splenectomy. Liver Transpl 2012;18:1361-70. [DOI: 10.1002/lt.23519] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
58 Carrapita J, Abrantes AM, Campelos S, Gonçalves AC, Cardoso D, Sarmento-Ribeiro AB, Rocha C, Santos JN, Botelho MF, Tralhão JG, Farges O, Barbosa JM. Impact of splenic artery ligation after major hepatectomy on liver function, regeneration and viability. Sci Rep 2016;6:34731. [PMID: 27725728 DOI: 10.1038/srep34731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
59 Kinjo N, Nagao Y, Akahoshi T, Masahiro K, Hashimoto N, Uehara H, Kawanaka H, Tomikawa M, Shirabe K, Hashizume M, Maehara Y. Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients: Predictors of improvement in hepatic function. Hepatol Res 2013;43:933-41. [DOI: 10.1111/hepr.12040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Kurihara T, Yoshizumi T, Yoshida Y, Ikegami T, Itoh S, Harimoto N, Ninomiya M, Uchiyama H, Okabe H, Kimura K. Graft selection strategy in adult-to-adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria. Liver Transpl. 2016;22:914-922. [PMID: 26953726 DOI: 10.1002/lt.24431] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
61 Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, Fine P, Menefee S, Ridgeway B, Visco A, Warren LK, Zhang M, Meikle S. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA 2013;309:2016-24. [PMID: 23677313 DOI: 10.1001/jama.2013.4919] [Cited by in Crossref: 343] [Cited by in F6Publishing: 284] [Article Influence: 38.1] [Reference Citation Analysis]
62 Ito K, Akamatsu N, Ichida A, Ito D, Kaneko J, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Splenectomy is not indicated in living donor liver transplantation. Liver Transpl 2016;22:1526-35. [PMID: 27253521 DOI: 10.1002/lt.24489] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
63 Yoshiya S, Harada N, Tomiyama T, Takeishi K, Toshima T, Iguchi T, Itoh S, Ninomiya M, Yoshizumi T, Mori M. The Significant Prognostic Factors in Prolonged Intensive/High Care Unit Stay After Living Donor Liver Transplantation. Transplant Proc 2021;53:1630-8. [PMID: 33934913 DOI: 10.1016/j.transproceed.2021.02.020] [Reference Citation Analysis]
64 Graham JA, Samstein B, Emond JC. Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome. Curr Transplant Rep. 2014;1:43-52. [PMID: 27280080 DOI: 10.1007/s40472-013-0006-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
65 Eipel C, Abshagen K, Ritter J, Cantré D, Menger MD, Vollmar B. Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver. Transpl Int. 2010;23:998-1007. [PMID: 20302595 DOI: 10.1111/j.1432-2277.2010.01079.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
66 Chu HC, Hsieh CB, Hsu KF, Fan HL, Hsieh TY, Chen TW. Simultaneous splenectomy during liver transplantation augments anti-viral therapy in patients infected with hepatitis C virus. Am J Surg 2015;209:180-6. [PMID: 24928331 DOI: 10.1016/j.amjsurg.2014.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
67 Kimura K, Ikegami T, Bekki Y, Ninomiya M, Yamashita Y, Yoshizumi T, Yoshiya S, Soejima Y, Harada N, Shirabe K. Clinical significance of gastrointestinal bleeding after living donor liver transplantation. Transpl Int. 2014;27:705-711. [PMID: 24673842 DOI: 10.1111/tri.12325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
68 Elshawy M, Toshima T, Asayama Y, Kubo Y, Ikeda S, Ikegami T, Arakaki S, Yoshizumi T, Mori M. Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation. Surg Case Rep 2020;6:164. [PMID: 32642985 DOI: 10.1186/s40792-020-00897-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Uchiyama H, Mano Y, Taketomi A, Soejima Y, Yoshizumi T, Ikegami T, Shirabe K, Maehara Y. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange. Transplantation. 2011;92:1134-1139. [PMID: 21946174 DOI: 10.1097/tp.0b013e318231e9f8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
70 Fukuhara T, Taketomi A, Motomura T, Okano S, Ninomiya A, Abe T, Uchiyama H, Soejima Y, Shirabe K, Matsuura Y. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology. 2010;139:1577-1585, 1585.e1-3. [PMID: 20708617 DOI: 10.1053/j.gastro.2010.07.058] [Cited by in Crossref: 173] [Cited by in F6Publishing: 160] [Article Influence: 14.4] [Reference Citation Analysis]
71 Nam NH, Taura K, Yao S, Kaido T, Uemoto Y, Kimura Y, Anazawa T, Fukumitsu K, Ito T, Yagi S, Kamo N, Hata K, Uemoto S. Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study. Transpl Int 2020;33:1807-20. [PMID: 33166011 DOI: 10.1111/tri.13761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Akamatsu N, Sugawara Y, Satou S, Mitsui T, Ninomiya R, Komagome M, Ozawa F, Beck Y. Hemodynamic changes in the hepatic circulation after the modulation of the splenic circulation in an in vivo human experimental model. Liver Transpl 2014;20:116-21. [DOI: 10.1002/lt.23763] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
73 Song G, Lee S, Moon D, Ahn C, Hwang S, Kim K, Ha T, Jung D. Dual-graft Adult Living Donor Liver Transplantation: An Innovative Surgical Procedure for Live Liver Donor Pool Expansion. Annals of Surgery 2017;266:10-8. [DOI: 10.1097/sla.0000000000001776] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 3.4] [Reference Citation Analysis]
74 Kawanaka H, Akahoshi T, Kinjo N, Iguchi T, Ninomiya M, Yamashita YI, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg 2014;101:1585-93. [PMID: 25200126 DOI: 10.1002/bjs.9622] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
75 Hirakawa Y, Ogata T, Sasada T, Yamashita T, Itoh K, Tanaka H, Okuda K. Immunological consequences following splenectomy in patients with liver cirrhosis. Exp Ther Med 2019;18:848-56. [PMID: 31281459 DOI: 10.3892/etm.2019.7640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Yoshiya S, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Kayashima H, Toshima T, Uchiyama H, Soejima Y, Maehara Y. The causes, risk factors, and outcomes of early relaparotomy after living-donor liver transplantation. Transplantation 2012;94:947-52. [PMID: 23034561 DOI: 10.1097/TP.0b013e31826969e6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
77 Morimoto H, Ishiyama K, Ishifuro M, Ohira M, Ide K, Tanaka Y, Tahara H, Teraoka Y, Yamashita M, Abe T, Hashimoto S, Hirata F, Tanimine N, Saeki Y, Shimizu S, Sakai H, Yano T, Tashiro H, Ohdan H. Clinical efficacy of simultaneous splenectomy in liver transplant recipients with hepatitis C virus. Transplant Proc 2014;46:770-3. [PMID: 24767345 DOI: 10.1016/j.transproceed.2013.12.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
78 He C, Liu X, Peng W, Li C, Wen TF. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis. Medicine (Baltimore) 2018;97:e0087. [PMID: 29517676 DOI: 10.1097/MD.0000000000010087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
79 Lauterio A, Di Sandro S, Giacomoni A, De Carlis L. The role of adult living donor liver transplantation and recent advances. Expert Rev Gastroenterol Hepatol. 2015;9:431-445. [PMID: 25307897 DOI: 10.1586/17474124.2015.967762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
80 Ikegami T, Shirabe K, Yoshizumi T, Yoshiya S, Toshima T, Motomura T, Soejima Y, Uchiyama H, Maehara Y. En Bloc Stapling Division of the Gastroesophageal Vessels Controlling Portal Hemodynamic Status in Living Donor Liver Transplantation. Journal of the American College of Surgeons 2012;214:e53-6. [DOI: 10.1016/j.jamcollsurg.2012.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
81 Katsuragawa H, Yamamoto M, Katagiri S, Yoshitoshi K, Ariizumi S, Kotera Y, Takahashi Y, Takasaki K. Graft size and donor age are independent factors for graft loss in adult-to-adult living-donor liver transplantation using the left liver. J Hepatobiliary Pancreat Surg. 2009;16:178-183. [PMID: 19165414 DOI: 10.1007/s00534-008-0026-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
82 Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, Mcgilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation: Right-Lobe Living Donor Liver Transplantation. Liver Transpl 2009;15:1776-82. [DOI: 10.1002/lt.21955] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
83 Onoe T, Tanaka Y, Ide K, Ishiyama K, Oshita A, Kobayashi T, Amano H, Tashiro H, Ohdan H. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation. Transplantation 2013;95:1521-7. [DOI: 10.1097/tp.0b013e31829150a4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
84 Chan KS, Low JK, Shelat VG. Associated liver partition and portal vein ligation for staged hepatectomy: a review. Transl Gastroenterol Hepatol 2020;5:37. [PMID: 32632388 DOI: 10.21037/tgh.2019.12.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Yoshizumi T, Shirabe K, Ikegami T, Yamashita N, Mano Y, Yoshiya S, Matono R, Harimoto N, Uchiyama H, Toshima T, Maehara Y. Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsis. Transpl Infect Dis 2014;16:225-31. [DOI: 10.1111/tid.12188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
86 Jin Y, Hu H, Regmi P, Li F, Cheng N. Treatment options for sclerosing angiomatoid nodular transformation of spleen. HPB (Oxford). 2020;22:1577-1582. [PMID: 32063479 DOI: 10.1016/j.hpb.2020.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
87 Kurihara T, Yoshizumi T, Ikegami T, Soejima Y, Maehara Y. Reply. Liver Transpl 2016;22:1743. [PMID: 27706897 DOI: 10.1002/lt.24648] [Reference Citation Analysis]
88 Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Fukuhara T, Kotoh K, Shimoda S, Kato M, Maehara Y. The Benefits of Interferon Treatment in Patients Without Sustained Viral Response After Living Donor Liver Transplantation for Hepatitis C. Transplantation Proceedings 2009;41:4246-52. [DOI: 10.1016/j.transproceed.2009.08.070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
89 Golriz M, El Sakka S, Majlesara A, Edalatpour A, Hafezi M, Rezaei N, Garoussi C, Arwin J, Saffari A, Raisi H, Abbasi A, Mehrabi A. Hepatic Hemodynamic Changes Following Stepwise Liver Resection. J Gastrointest Surg 2016;20:587-94. [PMID: 26573852 DOI: 10.1007/s11605-015-3021-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
90 Golse N, Bucur PO, Adam R, Castaing D, Sa Cunha A, Vibert E. New Paradigms in Post-hepatectomy Liver Failure. J Gastrointest Surg 2013;17:593-605. [DOI: 10.1007/s11605-012-2048-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
91 Russolillo N, Ratti F, Viganò L, Langella S, Cipriani F, Aldrighetti L, Ferrero A. The Influence of Aging on Hepatic Regeneration and Early Outcome after Portal Vein Occlusion: A Case-Control Study. Ann Surg Oncol 2015;22:4046-51. [PMID: 25758189 DOI: 10.1245/s10434-015-4478-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
92 Golriz M, Majlesara A, El Sakka S, Ashrafi M, Arwin J, Fard N, Raisi H, Edalatpour A, Mehrabi A. Small for Size and Flow (SFSF) syndrome: An alternative description for posthepatectomy liver failure. Clin Res Hepatol Gastroenterol. 2016;40:267-275. [PMID: 26516057 DOI: 10.1016/j.clinre.2015.06.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
93 Dagher NN. Living Donor Liver Transplantation: A Western Perspective. Int Anesthesiol Clin 2017;55:135-47. [PMID: 28288032 DOI: 10.1097/AIA.0000000000000135] [Reference Citation Analysis]
94 Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, Rautou PE. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2017;66:212-227. [PMID: 27423426 DOI: 10.1016/j.jhep.2016.07.009] [Cited by in Crossref: 324] [Cited by in F6Publishing: 307] [Article Influence: 54.0] [Reference Citation Analysis]